Skip to main content

Articles

FDA Approvals
Xofigo (Radium Ra 223 Dichloride): The First Alpha Particle–Emitting Radioactive Agent for the Treatment of Castration-Resistant Prostate Cancer with Symptomatic Bone Metastases
Read More
Perspectives
Cancer Care in 2013: Hope, Reality, and a Call to Action
Read More
Experts Debate Value of Bevacizumab in Newly Diagnosed Glioblastoma
Read More
Bevacizumab an Effective New Treatment Option for Relapsed Cervical Cancer
Read More
Sorafenib Effective in Metastatic Differentiated Thyroid Cancer
Read More
Prostate Cancer
New Analysis Confirms Radium Ra-223 Prolongs Survival in Patients with Metastatic CRPC, Regardless of Previous Docetaxel Therapy Status
Read More
Prostate Cancer
Lack of Knowledge Prevents Men with Early-Stage Prostate Cancer from Choosing Active Surveillance
Read More
Breast Cancer, Oncology
New Data Confirm Benefits of 10 Years Tamoxifen versus 5 Years in Patients with ER-Positive Breast Cancer
Read More
Lung Cancer, Oncology
Current Treatment of Advanced NSCLC Requires Testing for Driver Mutations
Read More
Lung Cancer, Oncology
Afatinib Doubles Progression-Free Survival Compared with Chemotherapy in Patients with Lung Cancer
Read More
Page 172 of 244
Results 1711 - 1720 of 2434